BioAtla, Inc. (BCAB) Tops Q2 EPS by 1c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• The Trade Desk (TTD) PT Raised to $14 at Evercore ISI
• Qualcomm (QCOM) call put ratio 4.8 calls to 1 put with a focus on September 11 weekly calls as share price up 4%